Genocure AI
Genocure AI is developing AI-powered solutions for oncology drug discovery and development.
About
Genocure AI combines next-generation genomics with powerful AI to guide smarter, personalized cancer treatments. Their advanced precision oncology platform, Supremeā¢, integrates multi-omic data with AI-driven algorithms to identify optimal therapeutic combinations for individual patients. They serve healthcare providers and the pharmaceutical industry, with future plans to assist patients directly. Teams look it up for Life Sciences, Oncology, Biotech.
Frequently asked
What does Genocure AI do?
Genocure AI is a Life Sciences company that offers Software. Teams look it up for Oncology, Biotech, Drug Discovery. It is based in San Francisco, United States and was founded in 2023. Public records show $10M in total funding. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Genocure AI raised?
Genocure AI has raised a total of $10M in funding. The most recent round on record is Seed.
Where is Genocure AI headquartered?
Genocure AI is headquartered in San Francisco, United States.
When was Genocure AI founded?
Genocure AI was founded in 2023.
What industry does Genocure AI operate in?
Genocure AI operates in Life Sciences, Oncology, Biotech, Drug Discovery, AI-Driven Drug Discovery.
Strength of the siteās backlink profile, on Ahrefsā 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the companyās own site. Measured by Google, not by us.